Psychotic experiences and psychiatric treatment utilization in Buenos Aires

Objective: Psychotic experiences are associated with psychiatric treatment utilization, though findings have not been entirely consistent. Furthermore, it is unclear how psychotic experiences relate to specific types of psychiatric treatment, and whether mental illness moderates these associations....

Full description

Saved in:
Bibliographic Details
Published in:International journal of social psychiatry 2020-06, Vol.66 (4), p.344-348
Main Authors: Oh, Hans, Koyanagi, Ai, DeVylder, Jordan E, Leiderman, Eduardo A
Format: Article
Language:English
Subjects:
Adolescent
Adult
Aged
Argentina - epidemiology
Comorbidity
Drugs
Female
Humans
Illnesses
Logistic Models
Male
Medical diagnosis
Mental disorders
Mental Disorders - epidemiology
Mental Disorders - therapy
Middle Aged
Multivariate Analysis
Psychological intervention
Psychopharmacology
Psychosis
Psychotherapy
Psychotropic Drugs - therapeutic use
Public spaces
Responsiveness
Sampling
Young Adult
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective: Psychotic experiences are associated with psychiatric treatment utilization, though findings have not been entirely consistent. Furthermore, it is unclear how psychotic experiences relate to specific types of psychiatric treatment, and whether mental illness moderates these associations. Methods: In total, 1,036 adult residents of Buenos Aires were recruited through convenience sampling in public places. Multivariable logistic regression models examined the associations between psychotic experiences and psychiatric treatment, adjusted for age, sex and education. Analyses were then stratified by diagnosis of mental illness. Results: Approximately 17.95% (N = 186) of the sample reported at least one psychotic experience over the past week, about 22.39% (N = 232) of the sample was receiving some psychiatric or psychological treatment and 8.59% (N = 89) was receiving psychopharmacological treatment. In the total sample, psychotic experiences were associated with greater odds of being in psychiatric/psychological treatment (adjusted odds ratio (AOR): 1.52; 95% confidence interval (CI): 1.05–2.21) and psychopharmacological treatment (AOR: 2.49; 95% CI: 1.52–4.09), adjusted for age, sex and education. Mental illness did not moderate the association between psychotic experiences and psychiatric/psychological treatment, but did moderate the association between psychotic experiences and psychopharmacological treatment. Among people with mental disorders, psychotic experiences were associated with greater odds of receiving psychopharmacological treatment (AOR: 14.63; 95% CI: 1.73–123.45) versus people without mental disorders (AOR: 1.75; 95% CI: 0.98–3.15). Conclusion: Psychotic experiences are associated with psychiatric treatment utilization, particularly psychopharmacological treatment among people with a co-occurring mental illnesses. Translational research should explore the utility of psychosis screens in assessing need for medication or clinical responsiveness to medications.
ISSN:0020-7640
1741-2854
DOI:10.1177/0020764020907628